RESEARCH PAPER
The association between blood cadmium levels and the risk of gastrointestinal cancer in Tabriz, northwest of Iran
A Ostadrahimi 1,   L Payahoo 1  
,   M H Somi 2,   S H Hashemzade 3,   A Esfahani 3,   M Asgharijafarabadi 4,   M Mobasseri 5,   N Samadi 6,   S Faraji 1,   Y KhajeBishak 1  
 
More details
Hide details
1
Nutrition Research Center, Student Research Committee, Department of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran
2
Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3
Nutrition Research Center, Student Research Committee, Department of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
4
Department of Epidemiology, Faculty of Health and Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran
5
Department of Internal Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
6
Department of Biochemistry and Laboratory Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Submission date: 2016-01-09
Acceptance date: 2016-05-11
Online publication date: 2016-08-23
Publication date: 2019-12-19
 
Pol. Ann. Med. 2017;24(2):133–137
 
KEYWORDS
ABSTRACT
Introduction:
Cancer is amajor health problem worldwide. Gastrointestinal tract malignancy is one of the most common forms of cancer around the world. Occupational exposure to the heavy metals including cadmium was defined as one of the most important environmental risk factors involved in initiation of cancer. Cadmium, a toxic and non-essential heavy metal, was classified as group 1 carcinogen.

Aim:
The aim of this study was to investigate the association between blood cadmium levels and the risk of gastrointestinal cancer in cancer patients.

Material and methods:
This descriptive study was carried out on 111 [42TD$DIF]gastrointestinal cancer patients as cases and 111 healthy people as controls from January to October 2013 in Tabriz, northwest of Iran. The protocol of this study is approved by the Ethics Committee in Tabriz University of Medical Science. Considering inclusion criteria, participants were selected randomly and a written informed consent was filled out for each patient. Demographic datawere obtained by questionnaire. Blood samples (5 mL) were collected from each patient in fasting status and analyzed by graphite furnace atomic absorption spectrophotometer (GFAAS).

Results and discussion:
Blood cadmium levels were significantly higher in cancer patients compared to healthy individuals (P = 0.037). The results of multivariate regression model did not show significant association between the concentrations of blood cadmium and the risk of gastrointestinal cancer: P = 0.137, OR = 1.15 (95% CI; 0.96–1.38).

Conclusions:
Our data suggest that finding individuals with high blood cadmium level and then lowering this amount can be considered as important strategy to prevent gastrointestinal cancer.

ACKNOWLEDGEMENTS
The authors thank the Vice Chancellor for Research (VCR) of Tabriz University of Medical Sciences (TUOMS), Nutrition Research Center and Department of Internal Medicine for supporting this study. This is a part of a database from thesis entitled “Evaluation of the dietary habits, urinary and blood cadmium of some gastrointestinal cancer patients with healthy people.”
CONFLICT OF INTEREST
There was no conflict of interest.
 
REFERENCES (39)
1.
Babaei M, Mousavi S, Malek M, et al. Cancer occurrence in Semnan Province, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev. 2005;6(2):159–164.
 
2.
Rathod CP, Dhawale SC, Kshirsagar RV. Recent trends in screening and evaluation methods of anticancer drugs. IAJPR. 2012;2(5):506–515.
 
3.
Cui XB, Peng H, Li S, et al. Prognostic value of PLCE1 expression in upper gastrointestinal cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2014;15(22):9661–9666.
 
4.
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386.
 
5.
Gao SR, Li LM, Xia HP, Wang GM, Xu HY, Wang AR. Clinical observation on recombinant human endostatin combined with chemotherapy for advanced gastrointestinal cancer. Asian Pac J Cancer Prev. 2015;16(9):4037–4040.
 
6.
Bishak YK, Payahoo L, Osatdrahimi A, Nourazarian A. Mechanisms of cadmium carcinogenicity in the gastrointestinal tract. Asian Pac J Cancer Prev. 2015;16(1):9–21.
 
7.
Parsa N. Environmental factors inducing human cancers. Iran J Public Health. 2012;41(11):1–9.
 
8.
Navarro Silvera SA, Rohan TE. Trace elements and cancer risk: a review of the epidemiologic evidence. Cancer Causes Control. 2007;18(1):7–27.
 
9.
McMurray CT, Tainer JA. Cancer, cadmium and genome integrity. Nat Genet. 2003;34(3):239–241.
 
10.
Waalkes MP, Rehm S, Cherian MG. Repeated cadmium exposures enhance the malignant progression of ensuing tumors in rats. Toxicol Sci. 2000;54(1):110–120.
 
11.
Shimada H, Shiao YH, Shibata M,Waalkes MP. Cadmium suppresses apoptosis induced by chromium. J Toxicol Environ Health A. 1998;54(2):159–168.
 
12.
Zheng H, Liu J, Choo KA, Michalska AE, Klaassen CD. Metallothionein-I and-II knock-out mice are sensitive to cadmium-induced liver mRNA expression of cjunandp53. Toxicol Appl Pharmacol. 1996;136(2):229–235.
 
13.
Abshire MK, Buzard GS, Shiraishi N,Waalkes MP. Induction of c-myc and c-jun proto-oncogene expression in rat L6 myoblasts by cadmium is inhibited by zinc preinduction of the metallothionein gene. J Toxicol Environ Health. 1996;48(4):359–377.
 
14.
Nawrot T, Plusquin M, Hogervorst J, et al. Environmental exposure to cadmium and risk of cancer: a prospective population-based study. Lancet Oncol. 2006;7(2):119–126.
 
15.
Alfvén T, Järup L, Elinder CG. Cadmium and lead in blood in relation to low bone mineral density and tubular proteinuria. Environ Health Perspect. 2002;110(7):699–702.
 
16.
Kriegel AM, Soliman AS, Zhang Q, et al. Serum cadmium levels in pancreatic cancer patients from the East Nile Delta region of Egypt. Environ Health Perspect. 2006;114(1):113–119.
 
17.
Kellen E, Zeegers MP, Den Hond E, Buntinx F. Blood cadmium may be associated with bladder carcinogenesis: the Belgian case–control study on bladder cancer. Cancer Detect Prev. 2007;31(1):77–82.
 
18.
Welna M, Szymczycha-Madeja A, Pohl P. Quality of the trace element analysis: sample preparation steps. In: Akyar I, ed. Wide Spectra of Quality Control. INTECH; 2011. Chapter 4 http://www.intechopen.com/book....
 
19.
Palanisamy Pasupathi SP. Chronic tobacco smoking and gastric cancer: a review. Int J Curr Biomed Pharm Res. 2011;1:48–66.
 
20.
Hogervorst J, Plusquin M, Vangronsveld J, et al. House dust as possible route of environmental exposure to cadmium and lead in the adult general population. Environ Res. 2007;103(1):30–37.
 
21.
Joseph P. Mechanisms of cadmium carcinogenesis. Toxicol App Pharmacol. 2009;238(3):272–279.
 
22.
Il'yasova D, Schwartz GG. Cadmium and renal cancer. Toxicol Appl Pharmacol. 2005;207(2):179–186.
 
23.
Strumylaite L, Bogusevicius A, Ryselis S, et al. Association between cadmium and breast cancer. Medicina (Kaunas). 2008;44(6)415–420 [in Lithuanian].
 
24.
Nagata C, Nagao Y, Nakamura K, et al. Cadmium exposure and the risk of breast cancer in Japanese women. Breast Cancer Res Treat. 2013;138(1):235–239.
 
25.
Gallagher CM, Chen JJ, Kovach JS. Environmental cadmium and breast cancer risk. Aging (Albany NY). 2010;2(11):804–814.
 
26.
Li J, Bostick RM,Ward KC. Cadmium, sexually transmitted disease, and risk for prostate cancer. Open Epidemiol J. 2009;2:14–19.
 
27.
Luckett BG, Su LJ, Rood JC, Fontham ET. Cadmium exposure and pancreatic cancer in south Louisiana. J Environ Public Health. 2012;2012:180186.
 
28.
Schwartz GG, Reis IM. Is cadmium a cause of human pancreatic cancer? Cancer Epidemiol Biomarkers Prev. 2000;9(2):139–145.
 
29.
Filipic M, Fatur T, Vudrag M. Molecular mechanisms of cadmium induced mutagenicity. Hum Exp Toxicol. 2006;25(2):67–77.
 
30.
Hartwig A. Cadmium and cancer. Met Ions Life Sci. 2013;11:491–507.
 
31.
Benbrahim-Talla L, Liu J, Webber MM, Waalkes MP. Estrogen signaling and disruption of androgen metabolism in acquired androgen-independence during cadmium carcinogenesis in human prostate epithelial cells. Prostate. 2007;67(2):135–145.
 
32.
Waalkes MP. Cadmium carcinogenesis. Mutat Res. 2003;533(1–2):107–120.
 
33.
Nordberg GF. Historical perspectives on cadmium toxicology. Toxicol Appl Pharmacol. 2009;238(3):192–200.
 
34.
González-Estecha M, Trasobares E, Fuentes M, et al. Blood lead and cadmium levels in a six hospital employee population PESA study, 2009. J Trace Elem Med Biol. 2011;25:S22–S29.
 
35.
dell'Omo M, Muzi G, Piccinini R, et al. Blood cadmium concentrations in the general population of Umbria, central Italy. Sci Total Environ. 1999;226(1):57–64.
 
36.
Olsson M, Bensryd I, Lundh T, Ottosson H, Skerfving S, Oskarsson A. Cadmium in blood and urine–impact of sex, age, dietary intake, iron status, and former smoking–association of renal effects. Environ Health Perspect. 2002;110(12):1185–1190.
 
37.
Kim DW, Woo HD, Joo J, et al. Estimated long-term dietary exposure to lead, cadmium, and mercury in young Korean children. Eur J Clin Nutr. 2014;68(12):1322–1326.
 
38.
Dguimi HM, Debouba M, Ghorbel MH, Gouia H. Tissue-specific cadmium accumulation and its effects on nitrogen metabolism in tobacco (Nicotiana tabaccum, Bureley v. Fb9). CR Biol. 2009;332(1):58–68.
 
39.
Zaprjanova P, Dospatliev L, Angelova V, Ivanov K. Correlation between soil characteristics and lead and cadmium content in the aboveground biomass of Virginia tobacco. Environ Monit Assess. 2010;163(1–4):253–261.